Usana Health Sciences (USNA) Return on Invested Capital (2015 - 2026)

Usana Health Sciences (USNA) has reported Return on Invested Capital for 7 consecutive years, with 0.0% the latest figure, recorded in Q2 2026.

• In Q2 2026, Return on Invested Capital fell 1.0% year-over-year to 0.0%; the TTM figure through Apr 2026 stood at 0.0% (down 1.0% YoY), while the FY2026 annual figure was 0.01%, down 3.0% from the prior year.
• Return on Invested Capital steadied at 0.0% in Q2 2026 per USNA's latest filing, from 0.0% in the prior quarter.
• Across five years, Return on Invested Capital topped out at 0.39% in Q1 2024 and bottomed at 0.0% in Q2 2026.
• Historically, Return on Invested Capital has averaged 0.1% across 4 years, with a median of 0.05% in 2022.
• Annual changes were most pronounced in 2025 — Return on Invested Capital tumbled 38 bps — and 2026, when it decreased 1 bps.
• Usana Health Sciences' Return on Invested Capital stood at 0.07% in 2022, then slumped by 60 bps to 0.03% in 2024, then slumped by 88 bps to 0.0% in 2025, then retreated by 25 bps to 0.0% in 2026.
• Business Quant data shows USNA's Return on Invested Capital at 0.0% in Q2 2026, 0.0% in Q1 2026, and 0.0% in Q3 2025.